Suenaga Kaori, Kitahara Shuji, Suzuki Yasuhiro, Kobayashi Miho, Horie Sachiko, Sugawara Junichi, Yaegashi Nobuo, Sato Yasufumi
Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan; Department of Obstetrics & Gynecology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan.
Department of Anatomy and Developmental Biology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
PLoS One. 2014 Sep 3;9(9):e104728. doi: 10.1371/journal.pone.0104728. eCollection 2014.
Vasohibin-1 (VASH1) and vasohibin-2 (VASH2), the 2 members of the vasohibin family, have been identified as novel regulators of angiogenesis. VASH1 ceases angiogenesis, whereas VASH2 stimulates sprouting. Here we characterized their functional role in the placenta. Immunohistochemical analysis of human placental tissue clarified their distinctive localization; VASH1 in endothelial cells and VASH2 in trophoblasts. We then used a mouse model to explore their function. Wild-type, Vash1((-/-)), and Vash2((-/-)) mice on a C57BL6 background were used in their first pregnancy. As expected, the fetal vascular area was increased in the Vash1((-/-)) mice, whereas it was decreased in the Vash2((-/-)) mice relative to wild-type. In addition, we noticed that the Vash2((-/-)) mice at 18.5dpc displayed thinner villi of the labyrinth and larger maternal lacunae. Careful observation by an electron microscopy revealed that the syncytiotrophoblast formation was defective in the Vash2((-/-)) mice. To test the possible involvement of VASH2 in the syncytiotrophoblast formation, we examined the fusion of BeWo cells, a human trophoblastoid choriocarcinoma cell line. The forskolin treatment induced the fusion of BeWo cells, and the knockdown of VASH2 expression significantly inhibited this cell fusion. Conversely, the overexpression of VASH2 by the infection with adenovirus vector encoding human VASH2 gene significantly increased the fusion of BeWo cells. Glial cell missing-1 and endogenous retrovirus envelope glycoprotein Syncytin 1 and Syncytin 2 are known to be involved in the fusion of trophoblasts. However, VASH2 did not alter their expression in BeWo cells. These results indicate that VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization. Moreover, our study shows for the first time that VASH2 expressed in trophoblasts is involved in the regulation of cell fusion for syncytiotrophoblast formation.
血管抑制素-1(VASH1)和血管抑制素-2(VASH2)是血管抑制素家族的两个成员,已被确定为血管生成的新型调节因子。VASH1抑制血管生成,而VASH2刺激血管芽生。在此,我们阐述了它们在胎盘中的功能作用。对人胎盘组织进行免疫组织化学分析明确了它们独特的定位;VASH1在内皮细胞中,VASH2在滋养层细胞中。然后我们使用小鼠模型来探究它们的功能。以C57BL6为背景的野生型、Vash1基因敲除(Vash1(-/-))和Vash2基因敲除(Vash2(-/-))小鼠用于首次妊娠实验。正如预期的那样,相对于野生型小鼠,Vash1(-/-)小鼠的胎儿血管面积增加,而Vash2(-/-)小鼠的胎儿血管面积减少。此外,我们注意到在妊娠第18.5天的Vash2(-/-)小鼠,其迷路绒毛更薄,母体血窦更大。通过电子显微镜仔细观察发现,Vash2(-/-)小鼠的合体滋养层细胞形成存在缺陷。为了测试VASH2可能参与合体滋养层细胞形成的情况,我们检测了人滋养层类绒毛膜癌细胞系BeWo细胞的融合情况。福斯高林处理可诱导BeWo细胞融合,而VASH2表达的敲低显著抑制了这种细胞融合。相反,通过感染编码人VASH2基因的腺病毒载体使VASH2过表达,显著增加了BeWo细胞的融合。已知神经胶质细胞缺失-1和内源性逆转录病毒包膜糖蛋白合体素-1及合体素-2参与滋养层细胞的融合。然而,VASH2并未改变它们在BeWo细胞中的表达。这些结果表明,VASH1和VASH2在胎儿胎盘血管形成上表现出独特的定位和相反的功能。此外,我们的研究首次表明,滋养层细胞中表达的VASH2参与了合体滋养层细胞形成的细胞融合调节。